Darmoń, J. et al. 2026. From GLP-1 Agonism to Triple-Receptor Therapy. Narrative Review of Semaglutide, Tirzepatide, and Retatrutide in Obesity Management. Quality in Sport. 54, (Apr. 2026), 70772. DOI:https://doi.org/10.12775/QS.2026.54.70772.